Chinese Premier Li Qiang has called for stronger policy support for the biotech industry, as part of efforts to bolster…
Read More »National Healthcare Security Administration
Beijing’s plan to publish China’s first list of innovative drugs eligible for coverage by commercial health insurance will draw keen…
Read More »British-Swedish pharmaceutical giant AstraZeneca endured a torrid time in China last year, as it underwent several investigations and saw one…
Read More »A number of major Chinese cities have reported worrisome deficits in their government-run health insurance funds, as rising medical costs…
Read More »China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »



